Daewoong Pharma

대웅제약 · 069620

Health Care Pharmaceuticals · KOSPI

Small-cap

Market cap US$1B (₩1.4T)

Overview

Company summary coming soon.

Source: DART · FY ending Dec · latest FY2025

Revenue · FY2025

US$1.1B

▲ +10.4% YoY

Operating profit · FY2025

US$142.6M

▲ +33.0% YoY

Net income · FY2025

US$139.8M

▲ +726.3% YoY

Revenue, operating profit and net income by fiscal year (USD; KRW in parentheses).
Metric	FY2023	FY2024	FY2025
Revenue	US$996.6M(₩1.4T)	US$1B(₩1.4T)	US$1.1B(₩1.6T)
Operating profit	US$88.8M(₩122.6B)	US$107.2M(₩147.9B)	US$142.6M(₩196.8B)
Net income	US$87M(₩120B)	US$16.9M(₩23.3B)	US$139.8M(₩192.9B)

Revenue

Operating profit

Net income

ROE

17.0%

Debt/Eq

108.2%

Op. margin

12.5%

Net margin

12.3%

Rev. YoY

▲ +10.4%

Interactive price history isn't here yet. Would you use it?